Literature DB >> 13738819

The Stuart-Prower factor: utilization of clotting factors obtained by starch-block electrophoresis for genetic evaluation.

S F RABINER, N KRETCHMER.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION

Mesh：

Substances：

Year:  1961        PMID： 13738819     DOI： 10.1111/j.1365-2141.1961.tb00322.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  [CONGENITAL STEWART-PROWER FACTOR (FACTOR X) DEFICIENCY].

Authors:  F HOLZKNECHT
Journal:  Klin Wochenschr       Date:  1965-01-15

Review 2.  [THE STUART-PROWER FACTOR: ITS COAGULATION PHYSIOLOGY AND CLINICAL SIGNIFICANCE].

Authors:  V HIEMEYER; M H HOERDER
Journal:  Klin Wochenschr       Date:  1964-11-15

Review 3.  Genetics of human blood coagulation.

Authors:  C B Kerr
Journal:  J Med Genet       Date:  1965-12       Impact factor: 6.318

4.  Observations on the separate assessment of Prower-Stuart factor activities.

Authors:  C GARDIKAS; C LYBERATOS; G KALLINIKOS; M KALLINIKOU
Journal:  J Clin Pathol       Date:  1962-11       Impact factor: 3.411

5.  Effects of bacterial endotoxin on rabbit platelets. II. Enhancement of platelet factor 3 activity in vitro and in vivo.

Authors:  H I HOROWITZ; R M DES PREZ; E W HOOK
Journal:  J Exp Med       Date:  1962-11-01       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.